Clinical trial

ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression

NCT05434156

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-10-27

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2022-10-27Date precision: day

Registry last updated2025-02-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthy Volunteersunresolved

Major Depressive Disorderunresolved

Depressionunresolved

Interventions

ELE-101DRUG

ELE-101 PlaceboDRUG

Sponsors & collaborators

Eleusis Therapeuticslead sponsor

Beckley Psytech Limitedcollaborator

Mapped research locations

ManchesterUnited Kingdom1 LiverpoolUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05434156 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.